A carregar...
Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice
Fingolimod is a multiple sclerosis treatment licensed in Europe since 2011. Its efficacy has been demonstrated in three large phase III trials, used in the regulatory submissions throughout the world. As usual, in these trials the inclusion and exclusion criteria were designed to obtain a homogeneou...
Na minha lista:
Publicado no: | Neurosci J |
---|---|
Autor principal: | |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Hindawi Publishing Corporation
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674597/ https://ncbi.nlm.nih.gov/pubmed/26693475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/389360 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|